Anebulo Pharmaceuticals, Inc. 10-Q filing
Filed 2026-02-12 · Report date 2025-12-31 · 2025
Filing metadata
- Accession number
- 0001493152-26-006446
- Form type
- 10-Q
- CIK
- 0001815974
- Primary document
- https://www.sec.gov/Archives/edgar/data/1815974/000149315226006446/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Anebulo Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-4.9M | - | - |
| Net Income | $-4.2M | - | - |
| Eps Basic | -0.1 | - | - |
| Eps Diluted | -0.1 | - | - |
| Cash And Equivalents | $9.0M | - | - |
| Total Assets | $9.4M | - | - |
| Total Liabilities | $1.5M | - | - |
| Shareholders Equity | $7.9M | - | - |
| Operating Cash Flow | $-2.6M | - | - |